NO964022D0 - -2-antichymotrypsinanaloger med elastasehemmende aktivitet - Google Patents

-2-antichymotrypsinanaloger med elastasehemmende aktivitet

Info

Publication number
NO964022D0
NO964022D0 NO964022A NO964022A NO964022D0 NO 964022 D0 NO964022 D0 NO 964022D0 NO 964022 A NO964022 A NO 964022A NO 964022 A NO964022 A NO 964022A NO 964022 D0 NO964022 D0 NO 964022D0
Authority
NO
Norway
Prior art keywords
inhibitory activity
elastase inhibitory
antichymotrypsin analogues
antichymotrypsin
analogues
Prior art date
Application number
NO964022A
Other languages
English (en)
Norwegian (no)
Other versions
NO964022L (no
Inventor
Barry Cooperman
Harvey Rubin
Norman Schechter
Zhi Mei Wang
Original Assignee
Trustees Of The Untiversity Of
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Trustees Of The Untiversity Of filed Critical Trustees Of The Untiversity Of
Publication of NO964022L publication Critical patent/NO964022L/no
Publication of NO964022D0 publication Critical patent/NO964022D0/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
    • C07K14/8121—Serpins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
    • C07K14/8121—Serpins
    • C07K14/8125—Alpha-1-antitrypsin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Rheumatology (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
NO964022A 1994-03-31 1996-09-24 -2-antichymotrypsinanaloger med elastasehemmende aktivitet NO964022D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/221,078 US5674708A (en) 1989-06-23 1994-03-31 α-1-antichymotrypsin analogues having elastase inhibitory activity
PCT/US1994/004735 WO1995027055A1 (en) 1994-03-31 1994-04-29 α-1-ANTICHYMOTRYPSIN ANALOGUES HAVING ELASTASE INHIBITORY ACTIVITY

Publications (2)

Publication Number Publication Date
NO964022L NO964022L (no) 1996-09-24
NO964022D0 true NO964022D0 (no) 1996-09-24

Family

ID=22826247

Family Applications (1)

Application Number Title Priority Date Filing Date
NO964022A NO964022D0 (no) 1994-03-31 1996-09-24 -2-antichymotrypsinanaloger med elastasehemmende aktivitet

Country Status (17)

Country Link
US (1) US5674708A (hu)
EP (1) EP0754228A4 (hu)
JP (1) JPH09512423A (hu)
CN (1) CN1145637A (hu)
AU (1) AU696995B2 (hu)
BG (1) BG100939A (hu)
CA (1) CA2186908A1 (hu)
CZ (1) CZ281796A3 (hu)
FI (1) FI963891A (hu)
HU (1) HUT74901A (hu)
LV (1) LV11747B (hu)
NO (1) NO964022D0 (hu)
NZ (1) NZ269619A (hu)
PL (1) PL316433A1 (hu)
SI (1) SI9420082A (hu)
SK (1) SK138196A3 (hu)
WO (1) WO1995027055A1 (hu)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5723316A (en) * 1989-06-23 1998-03-03 Trustees Of The University Of Pennsylvania α-1-antichymotrypsin analogues having chymase inhibiting activity
US5827662A (en) * 1989-06-23 1998-10-27 The Trustees Of The University Of Pennsylvania Methods for detecting genetic mutations resulting in protease inhibitor insufficiencies
US6458777B1 (en) 1998-03-13 2002-10-01 Mucosal Therapeutics Llc Methods and compositions for treating and preventing mucositis
US6242473B1 (en) * 1999-01-08 2001-06-05 Maxim Pharmaceuticals, Inc. Treatment and prevention of reactive oxygen metabolite-mediated cellular damage
AU2001292306A1 (en) * 2000-09-29 2002-04-08 Ono Pharmaceutical Co. Ltd. Remedies for inflammatory bowel diseases
ES2239715T3 (es) * 2001-04-30 2005-10-01 Switch Biotech Aktiengesellschaft Utilizacion de la alfa-1 quimotripsina en la preparacion de una composicion para el tratamiento, prevencion o diagnostico de las heridas de dificil cicatrizacion causadas por la diabetes.
DE10121255A1 (de) 2001-04-30 2002-11-07 Switch Biotech Ag Verwendung von alpha 1-Antichymotrypsin Polypeptiden oder diese kodierende Nukleinsäuren, oder einer ein ACT Polypeptid oder diese kodierende Nukleinsäure exprimierende Zelle, zur Behandlung und/oder Prävention von diabetes-assoziierten und/oder arteriellen schlecht heilenden Wunden und zur Identifizierung von pharmakologisch aktiven Substanzen
EP1415664A1 (en) * 2002-10-30 2004-05-06 Switch Biotech Aktiengesellschaft Use of alpha 1-antichymotrypsin in combination with alpha-1-antitrypsin for treating/preventing diabetes associated or poorly healing arterial wounds
CA2623957A1 (en) * 2005-09-29 2007-04-05 University Of Alberta Compositions for and methods of granzyme b inhibition
US10531655B2 (en) 2011-12-02 2020-01-14 The Regents Of The University Of California Reperfusion protection solution and uses thereof
WO2021020509A1 (ja) * 2019-07-31 2021-02-04 株式会社ステムリム 間葉系幹細胞の増殖促進または減少抑制のための組成物
US20210051956A1 (en) * 2019-08-23 2021-02-25 The Hong Kong University Of Science And Technology Elasnin, a bacteriostatic agent that has potent antibiofilm activities against both mono- and multi-species biofilm
WO2021053058A1 (en) 2019-09-17 2021-03-25 Mereo Biopharma 4 Limited Alvelestat for use in the treatment of graft rejection, bronchiolitis obliterans syndrome and graft versus host disease
MX2022012942A (es) 2020-04-16 2023-01-11 Mereo Biopharma 4 Ltd Metodos que involucran el inhibidor de la elastasa de neutrofilo alvelestat para el tratamiento de enfermedades respiratorias mediadas por deficiencia de alfa-1 antitripsina.
AU2022373971A1 (en) 2021-10-20 2024-04-04 Mereo Biopharma 4 Limited Neutrophil elastase inhibitors for use in the treatment of fibrosis

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4732973A (en) * 1984-06-14 1988-03-22 Chiron Corporation Active site modified protease α-1-antitrypsin inhibitors
US4916117A (en) * 1986-12-24 1990-04-10 John Lezdey Treatment of inflammation using alpha 1-antichymotrypsin
US5008242A (en) * 1986-12-24 1991-04-16 John Lezdey Treatment of inflammation using 1-antichymotrypsin
US5079336A (en) * 1989-06-23 1992-01-07 The Trustees Of The University Of Pennsylvania α-1-antichymotrypsin, analogues and methods of production
US5252725A (en) * 1989-06-23 1993-10-12 The Trustees Of The University Of Pennsylvania α-1-antichymotrypsin, analogues and methods of production
US5723316A (en) * 1989-06-23 1998-03-03 Trustees Of The University Of Pennsylvania α-1-antichymotrypsin analogues having chymase inhibiting activity
US5266465A (en) * 1989-06-23 1993-11-30 The Trustees Of The University Of Pennsylvania α-1-antichymotrypsin, analogues and methods of production

Also Published As

Publication number Publication date
HU9602674D0 (en) 1996-11-28
US5674708A (en) 1997-10-07
NO964022L (no) 1996-09-24
JPH09512423A (ja) 1997-12-16
LV11747A (lv) 1997-04-20
BG100939A (en) 1997-10-31
FI963891A0 (fi) 1996-09-27
EP0754228A4 (en) 1997-12-10
HUT74901A (en) 1997-02-28
SK138196A3 (en) 1997-07-09
AU7393694A (en) 1995-10-23
CN1145637A (zh) 1997-03-19
NZ269619A (en) 1998-01-26
AU696995B2 (en) 1998-09-24
FI963891A (fi) 1996-09-27
EP0754228A1 (en) 1997-01-22
SI9420082A (en) 1997-06-30
PL316433A1 (en) 1997-01-06
CA2186908A1 (en) 1995-10-12
WO1995027055A1 (en) 1995-10-12
CZ281796A3 (en) 1997-05-14
LV11747B (en) 1997-10-20

Similar Documents

Publication Publication Date Title
DE69511326D1 (de) Spülgerät
FI971608A0 (fi) Kiinnitin
NO964022D0 (no) -2-antichymotrypsinanaloger med elastasehemmende aktivitet
NO992103D0 (no) Dihydropyroner med forbedret antiviral aktivitet
DE9407329U1 (de) Verbindungselement
DK0731078T3 (da) Terpenquinon med antitumoraktivitet
DE9407875U1 (de) Befestigungselement
DE29518630U1 (de) Geschirrspülmaschine
DE29520289U1 (de) Befestigung
DE59507080D1 (de) Befestigungselement
DE9420620U1 (de) Einstückiges Befestigungselement
KR960003822U (ko) 주방용 선반
DE9414884U1 (de) Verbindungselement
DE9416562U1 (de) Verbindungselement
DE9405202U1 (de) Verbindungselement
DE9420094U1 (de) Verbindungselement
DE9420762U1 (de) Verbindungselement
KR960014916U (ko) 풀림방지용 로크너트
KR960002244U (ko) 풀림방지용 편심 너트
DK9400264U3 (da) Bordskånedug
KR960003878U (ko) 식기
KR950029517U (ko) 주방용 수세미
KR950024249U (ko) 주방용 장갑
FI1363U1 (fi) Anlaeggning i pappersmaskin i samband med kantsprutroeren
FI1727U1 (fi) Ansiktsskydd i samband med haortvaettning

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application